Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.
Cancers (Basel). 2022 Mar 22;14(7):1609. doi: 10.3390/cancers14071609.
Cancers (Basel). 2022.
PMID: 35406381
Free PMC article.
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors.
Decourtye-Espiard L, Bougen-Zhukov N, Godwin T, Brew T, Schulpen E, Black MA, Guilford P.
Decourtye-Espiard L, et al.
Cancers (Basel). 2021 Dec 30;14(1):175. doi: 10.3390/cancers14010175.
Cancers (Basel). 2021.
PMID: 35008338
Free PMC article.
Item in Clipboard
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking.
Brew T, Bougen-Zhukov N, Mitchell W, Decourtye L, Schulpen E, Nouri Y, Godwin T, Guilford P.
Brew T, et al.
Cancers (Basel). 2021 Dec 26;14(1):102. doi: 10.3390/cancers14010102.
Cancers (Basel). 2021.
PMID: 35008266
Free PMC article.
Item in Clipboard
Cite
Cite